ARVO: Hydroxychloroquine Daily Dosing Recs Often Exceeded

Share this content:
ARVO: Hydroxychloroquine Daily Dosing Recs Often Exceeded
ARVO: Hydroxychloroquine Daily Dosing Recs Often Exceeded

TUESDAY, May 5, 2015 (HealthDay News) -- Many patients prescribed hydroxychloroquine exceed the safety guidelines for daily dosing, according to a study presented at the annual meeting of the Association for Research in Vision and Ophthalmology, held from May 3 to 7 in Denver.

Jing Grace Wang, D.O., Ph.D., and Jonathan Levine, M.D., from the Bronx-Lebanon Hospital Center in New York, examined hospital adherence to the American Academy of Ophthalmology guidelines for monitoring the ocular toxicity from hydroxychloroquine at an inner-city hospital. The authors collected data for daily doses for all patients who were prescribed hydroxychloroquine. The maximal safe daily dose was calculated based on 6.5 mg/kg of ideal body weight for each patient. To determine the safe dosing, the actual daily dose was compared to the maximal safe daily dose. Data were included for 643 patients (86 percent female; 62 percent Hispanic; average age, 52 years).

The researchers found that in 86 percent of patients the daily dosage of hydroxychloroquine was 400 mg. Overall, 70 percent of patients had daily doses that exceeded the recommended 6.5 mg/kg of ideal body weight.

"More effective communication may be required between the Department of Ophthalmology and prescribing physicians regarding retinopathy status and detection of potentially toxic dosing," the authors write. "However, the dosing decision for each patient ultimately depends on the judgment of the prescribing physician, and requires weighing all the risks and benefits of different dosing levels."

Abstract No. 1793-A0226
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »